Dina Abushanab

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 27

Top Topics

Systematic Review

Cardiovascular Disease

Top Venues

PharmacoEconomics

Journal of pharmaceutical policy and practice

Journal of medical economics

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Waleed Salem, Palli Valappila Abdul Rouf, Binny Thomas, Wessam El Kassem, Dina Abushanab, Haseebur Rahman Khan, Yolande Hanssens, Rajvir Singh, Hany A Zaki, Aftab Mohammed Azad, Moza Al Hail, Shaban Mohammed
Epidemiology, clinical characteristics, and associated cost of acute poisoning: a retrospective study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Ola Yakti, Daoud Al-Badriyeh, Mohammed Rijims, Mohammed Abdelaal, Omar Alsoukhni, Moza Al Hail, Palli Valapila Abdulrouf, Wessam El-Kassem, Fouad Abounahia, Rasha Kaddoura, Dina Abushanab
Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis. Journal of pharmaceutical policy and practice 17 (1) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Ola Yakti, Daoud Al-Badriyeh, Mohammed Rijims, Mohammed Abdelaal, Omar Alsoukhni, Moza Al Hail, Palli Valapila Abdulrouf, Wessam El-Kassem, Fouad Abounahia, Rasha Kaddoura, Dina Abushanab
Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis. Journal of pharmaceutical policy and practice 17 (1) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics (2024)
Eilan Al-Hersh, Dina Abushanab, Fouad AbouNahia, Daniel Rainkie, Moza Al Hail, Palli Valapila Abdulrouf, Wessam El-Kassem, Daoud Al-Badriyeh
A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit. Journal of pharmaceutical policy and practice 17 (1) (2024)
Dina Abushanab, Wafa Al-Marridi, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam El Kassem, Binny Thomas, Hussam Alsoub, Zanfina Ademi, Yolande Hanssens, Rasha El Enany, Daoud Al-Badriyeh
The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar. Journal of pharmaceutical policy and practice 17 (1) (2024)
Waleed Salem, Palli Valappila Abdul Rouf, Binny Thomas, Wessam El Kassem, Dina Abushanab, Haseebur Rahman Khan, Yolande Hanssens, Rajvir Singh, Hany A Zaki, Aftab Mohammed Azad, Moza Al Hail, Shaban Mohammed
Epidemiology, clinical characteristics, and associated cost of acute poisoning: a retrospective study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Dina Abushanab, Salma Chbib, Rasha Kaddoura, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam El Kassem, Jassim Shah, Ramesh Kumar Ravindran Nair, Daoud Al-Badriyeh
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes. Journal of medical economics 27 (1) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Eilan Al-Hersh, Dina Abushanab, Fouad AbouNahia, Daniel Rainkie, Moza Al Hail, Palli Valapila Abdulrouf, Wessam El-Kassem, Daoud Al-Badriyeh
A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit. Journal of pharmaceutical policy and practice 17 (1) (2024)
Dina Abushanab, Salma Chbib, Rasha Kaddoura, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam El Kassem, Jassim Shah, Ramesh Kumar Ravindran Nair, Daoud Al-Badriyeh
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes. Journal of medical economics 27 (1) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Dina Abushanab, Daoud Al-Badriyeh, Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Ella Zomer, Stella Samoborec, Danny Liew, Zanfina Ademi
The Reduction of the Productivity Burden of Cardiovascular Disease by Improving the Risk Factor Control Among Australians with Type 2 Diabetes: A 10-Year Dynamic Analysis. European journal of preventive cardiology (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Clara Marquina, Jedidiah I Morton, Melanie A Lloyd, Dina Abushanab, Yeji Baek, Tamrat Befekadu Abebe, Adam C Livori MClinPharm, Padam Kanta Dahal, Gerald F Watts, Zanfina Ademi
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review. PharmacoEconomics 42 (4) (2024)
Dina Abushanab, Salma Chbib, Rasha Kaddoura, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam El-Kassem, Jassim Shah, Ramesh Nair, Daoud Al-Badriyeh
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes. Journal of medical economics (2024)
Dina Abushanab, Wafa Al-Marridi, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam El Kassem, Binny Thomas, Hussam Alsoub, Zanfina Ademi, Yolande Hanssens, Rasha El Enany, Daoud Al-Badriyeh
The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar. Journal of pharmaceutical policy and practice 17 (1) (2024)
Myriam Jaam, Hend Nasser Al-Naimi, Moumena Mahmoud Haddad, Dina Abushanab, Daoud Al-Badriyeh
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis. Journal of comparative effectiveness research (2023)
Myriam Jaam, Hend Nasser Al-Naimi, Moumena Mahmoud Haddad, Dina Abushanab, Daoud Al-Badriyeh
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis. Journal of comparative effectiveness research 12 (3) (2023)
Sara Al Dali, Daoud Al-Badriyeh, Amaal Gulied, Anas Hamad, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam El-Kassem, Dina Abushanab
Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Myriam Jaam, Hend Nasser Al-Naimi, Moumena Mahmoud Haddad, Dina Abushanab, Daoud Al-Badriyeh
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis. Journal of comparative effectiveness research 12 (3) (2023)
Dina Abushanab, Daoud Al-Badriyeh, Clara Marquina, Danny Liew, Manal Al-Zaidan, Mohamed Ghaith Al-Kuwari, Jazeel Abdulmajeed, Zanfina Ademi
Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10-year forecasting model. Diabetes, obesity & metabolism (2023)
Dina Abushanab, Clara Marquina, Jedidiah I Morton, Daoud Al-Badriyeh, Melanie A Lloyd, Dianna J Magliano, Danny Liew, Zanfina Ademi
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031. PharmacoEconomics (2023)